RBMO Shares New Findings on Cell Number Biopsied During PGT-A
Reproductive BioMedicine Online (RBMO) shared a post on LinkedIn:
“This study investigates the effect on diagnostic and clinical outcomes of the number of trophectoderm cells biopsied during blastocyst-stage PGT-A.
The findings suggest that the diagnostic failure rate may be comparable regardless of the number of cells biopsied, after adjustment for potential confounders in multivariable analyses. Minimizing the number of cells biopsied may reduce embryo injury, supporting the need for standardized biopsy protocols that consider both diagnostic yield and embryo preservation.
The authors say their findings emphasize the need for standardized, evidence-based biopsy protocols that consider both diagnostic yield and embryo preservation.
RBMO subscribers can read the full paper from our in-press articles section now.”
Title: Impact of the number of trophectoderm cells biopsied on the quality of preimplantation genetic testing for aneuploidy
Authors: Chiao-Hsin Kung, Che-Min Chen, Ni-Chin Tsai, Yu-Ting Su, Yu-Ju Lin, Fu-Tsai Kung, Kuo-Chung Lan
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 30, 2026, 02:02Sandro Esteves and Marcos Meseguer: From Biology to Bedside in Male Infertility
-
Apr 29, 2026, 12:34Inclusive Guidance for People Exploring Donor Conception – London Sperm Bank
-
Apr 29, 2026, 12:07International Donor Conception Awareness Day – HFEA
-
Apr 29, 2026, 11:56Infertility Treatment Access as NIAW2026 Comes to a Close – ASRM
-
Apr 29, 2026, 11:31RCOG Opens New Webinar Series to Support O and G Surgical Skills Training
-
Apr 29, 2026, 11:22Pauline Saint Martin: Victims of Violence, Screening and Health Consequences in Focus in New Webinar
-
Apr 29, 2026, 10:56Christopher Robinson: Isolated Severe Systolic Hypertension During Delivery Admission and Maternal Outcomes
-
Apr 29, 2026, 10:49Risks, Costs and Evidence Behind Fertility Add-Ons – HFEA
-
Apr 29, 2026, 10:29Estradiol Levels and Embryo Development in IVF – RBMO